AtriCure Wins Panel Backing for Irregular Heartbeat Device

The benefits of AtriCure Inc.’s device to treat an irregular heartbeat during open-heart surgery outweigh the risks, advisers to U.S. regulators said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.